Johnson & Jonson’s medical devices segment reported a 6.9 percent sales decrease in the second quarter to $6.4 billion. Overall, second quarter orthopedics sales dropped 1.6 percent to $2.2 billion and worldwide orthopedic sales at the six months end dropped 2 percent to $4.4 billion. U.S. spine sales dropped $1.5 percent to $490 million for the quarter, and worldwide spine sales were down 3
Medtronic reported fourth quarter revenue increased 2 percent to $30.5 billion, however the spine business experienced a slight decline. Fourth quarter spine revenue hit $691 million, a 1.1 percent decrease year over year. When combining the spine sales with sales-related to enabling technologies — Medtronic’s robotics, navigation, imaging and powered surgical instruments — spine-related revenue increased in the mid-single digits.
Smith & Nephew reported second quarter revenue increased 3.5 percent in 2019, with a strong performance in the company’s emerging markets and sports medicine. The company’s revenue hit $1.2 billion for the quarter, including $552 million from the orthopedics line. Orthopedics revenue was up 3.6 percent for the quarter.
Zimmer Biomet reported a net sales decrease of 0.9 percent to $1.99 billion during the second quarter. Spine and craniomaxillofacial sales decreased 6.2 percent year over year to $186 million.
Stryker reported an increase in overall sales, driven by a 3.7 percent jump in orthopedics sales during the second quarter. The company reported net sales increased 9.9 percent to $3.7 billion. Orthopedics sales were up 3.7 percent to $1.3 billion while spine and nanotechnology jumped 18.9 percent to $800 million. For the six months end, overall sales were up 9.2 percent to $7.1 billion
Integra LifeSciences posted second quarter revenues of $384 million, a 4.8 percent increase of the same period for last year. Extremity orthopedics revenues rose 1.2 percent to $22 million while the company reported a 6.1 percent increase in orthopedics and tissue technologies year over year, hitting $134 million.
In the second quarter of 2019, NuVasive reported a 3.7 percent year-over-year boost in revenues. Second-quarter revenues increased to $292.1 million from $281.6 million for the same period last year.
RTI Surgical’s worldwide revenues increased 16 percent from $70.7 million in the same period last year to $82.3 million in the second quarter of 2019. The company’s second quarter revenues were boosted from a $10.1 million global contribution made from the acquisition of Paradigm Spine, which closed in March.
Xtant Medical reported a net loss of $1.9 million, a 62 percent decrease year-over-year. The company posted $10.5 million in second quarter operating expenses, down 29 percent year-over-year.
SI-Bone posted a 19 percent revenue increase to $16.3 million for the second quarter. Gross profit was up 18 percent year over year to $14.8 million. The company also reported a net loss of $8.7 million during the second quarter, a 175 percent increase from the same period last year.
Alphatec posted a second quarter total net revenue of $27.3 million, a 28 percent increase for the same period last year. Total operating expenses rose 32.6 percent to $29.3 million and net loss increased 75.8 percent to $12.4 million when compared with the same period last year.
Orthofix reported net sales increased 3.9 percent in the second quarter, including $500,000 in sales of the M6-C cervical disc. The company’s net sales hit nearly $116 million, an almost 4 percent increase over the same period last year.
More articles on devices:
Why Dr. Dominic Thomas Kleinhenz joined University Orthopedics and the biggest obstacle in spine
Dr. Stephen Hochschuler: Future trends in spine – telemedicine, robotics, AI & more
Dr. Christopher Kager: The standout spine procedure in his career, future of biologics & more
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
